All In Biotech

Drug Trial Radar · NCT03340597

Assessment of Varying Oral Dosing Regimens for F901318 in Healthy Subjects

A Phase I, Open Label Study in Healthy Subjects to Evaluate the Safety, Tolerability and Pharmacokinetics of Varying Oral Dosing Regimens for F901318

Last checked: Nov 19, 2026Latest source record: Aug 2, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

45

Actual

Start

Dec 12, 2017

Primary completion

Apr 13, 2018

Study completion Apr 13, 2018

Sponsor

Lead sponsor
F2G LtdIndustry
Sponsor type
Industry
Collaborators
Covance
First posted
Nov 13, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Other
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Phase I, open label study evaluating safety, tolerability and pharmacokinetics of F901318 in healthy subjects following up to 28 days dosing, where F901318 is given orally . The effect of food upon the pharmacokinetics of F901318 and the effect of F901318 upon the pharmacokinetics of midazolam will also be assessed.

Conditions

  • Invasive Aspergillosis

Interventions

  • F901318Drug

    F901318 tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of treatment emergent adverse eventsTime frame: 18 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Covance Clinical Research Unit

    Leeds, West Yorkshire, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.